Citations to this article
Marina Doebbeler, … , Alexander Steinkasserer, Matthias Lechmann
Published June 7, 2018
Citation Information: JCI Insight. 2018;3(11):e99712. https://doi.org/10.1172/jci.insight.99712.
Citation Information: JCI Insight. 2018;3(11):e99712. https://doi.org/10.1172/jci.insight.99712.
Abstract
Foxp3-positive regulatory T cells (Tregs) are crucial for the maintenance of immune homeostasis and keep immune responses in check. Upon activation, Tregs are transferred into an effector state expressing transcripts essential for their suppressive activity, migration, and survival. However, it is not completely understood how different intrinsic and environmental factors control differentiation. Here, we present for the first time to our knowledge data suggesting that Treg-intrinsic expression of CD83 is essential for Treg differentiation upon activation. Interestingly, mice with Treg-intrinsic CD83 deficiency are characterized by a proinflammatory phenotype. Furthermore, the loss of CD83 expression by Tregs leads to the downregulation of Treg-specific differentiation markers and the induction of an inflammatory profile. In addition, Treg-specific conditional knockout mice showed aggravated autoimmunity and an impaired resolution of inflammation. Altogether, our results show that CD83 expression in Tregs is an essential factor for the development and function of effector Tregs upon activation. Since Tregs play a crucial role in the maintenance of immune tolerance and thus prevention of autoimmune disorders, our findings are also clinically relevant.
Authors
Marina Doebbeler, Christina Koenig, Lena Krzyzak, Christine Seitz, Andreas Wild, Thomas Ulas, Kevin Baßler, Dmitry Kopelyanskiy, Alina Butterhof, Christine Kuhnt, Simon Kreiser, Lena Stich, Elisabeth Zinser, Ilka Knippertz, Stefan Wirtz, Christin Riegel, Petra Hoffmann, Matthias Edinger, Lars Nitschke, Thomas Winkler, Joachim L. Schultze, Alexander Steinkasserer, Matthias Lechmann
Citation information
Citations to this article (35)
| Title and authors | Publication | Year |
|---|---|---|
|
Tissue‐Resident Regulatory T Cells Expressing CD83 Maintain Local Homeostasis and Restrict Th2 Responses in Asthma
Heiß A, Krammer S, Kuhnt C, Draßner C, Beck P, Geiger A, Schliep S, Geppert C, Steinkasserer A, Wild AB |
European Journal of Immunology | 2025 |
|
IL-23 stabilizes an effector T(reg) cell program in the tumor microenvironment.
Wertheimer T, Zwicky P, Rindlisbacher L, Sparano C, Vermeer M, de Melo BMS, Haftmann C, Rückert T, Sethi A, Schärli S, Huber A, Ingelfinger F, Xu C, Kim D, Häne P, Fonseca da Silva A, Muschaweckh A, Nunez N, Krishnarajah S, Köhler N, Zeiser R, Oukka M, Korn T, Tugues S, Becher B |
Nature Immunology | 2024 |
|
A Lacticaseibacillus rhamnosus secretome induces immunoregulatory transcriptional, functional and immunometabolic signatures in human THP-1 monocytes.
Jeffrey MP, Saleem L, MacPherson CW, Tompkins TA, Clarke ST, Green-Johnson JM |
Scientific Reports | 2024 |
|
γδ T cells: The first line of defense for neonates.
Gray JI, Farber DL |
Journal of Experimental Medicine | 2024 |
|
Exponential decline, ceiling effect, downregulation, and T-cell response in immunoglobulin G antibody levels after messenger RNA vaccine boosters: a case report
Hirano H, Asada H |
Journal of Medical Case Reports | 2024 |
|
Vimentin modulates regulatory T cell receptor-ligand interactions at distal pole complex, leading to dysregulated host response to viral pneumonia
Ma R, Prigge AD, Ortiz Serrano TP, Cheng Y, Davis JM, Lou KF, Wood WA, Chi Do H, Ren Z, Fulcer MM, Lotesto MJ, Singer BD, Coates BM, Ridge KM |
Cell reports | 2024 |
|
The Monocytic Cell Line THP-1 as a Validated and Robust Surrogate Model for Human Dendritic Cells
Hölken JM, Teusch N |
International journal of molecular sciences | 2023 |
|
CD83 Regulates the Immune Responses in Inflammatory Disorders
Riaz B, Islam SM, Ryu HM, Sohn S |
International journal of molecular sciences | 2023 |
|
CD83 expressed by macrophages is an important immune checkpoint molecule for the resolution of inflammation
Peckert-Maier K, Langguth P, Strack A, Stich L, Mühl-Zürbes P, Kuhnt C, Drassner C, Zinser E, Wrage M, Mattner J, Steinkasserer A, Royzman D, Wild AB |
Frontiers in immunology | 2023 |
|
CD83 expression characterizes precursor exhausted T cell population
Wu Z, Yoshikawa T, Inoue S, Ito Y, Kasuya H, Nakashima T, Zhang H, Kotaka S, Hosoda W, Suzuki S, Kagoya Y |
Communications biology | 2023 |
|
Roles of cuproptosis-related gene DLAT in various cancers: a bioinformatic analysis and preliminary verification on pro-survival autophagy
Yang Q, Zeng S, Liu W |
PeerJ | 2023 |
|
Porcine Reproductive and Respiratory Syndrome Virus Modulates the Switch of Macrophage Polarization from M1 to M2 by Upregulating MoDC-Released sCD83
Gong X, Ma T, Zhang Q, Wang Y, Song C, Lai M, Zhang C, Fang X, Chen X |
Viruses | 2023 |
|
Adenosine deaminase augments SARS-CoV-2 specific cellular and humoral responses in aged mouse models of immunization and challenge
Gary EN, Tursi NJ, Warner BM, Cuismano G, Connors J, Parzych EM, Griffin BD, Bell MR, Ali AR, Frase D, Hojecki CE, Canziani GA, Chaiken I, Kannan T, Moffat E, Embury-Hyatt C, Wooton SK, Kossenkov A, Patel A, Kobasa D, Kutzler MA, Haddad EK, Weiner DB |
Frontiers in immunology | 2023 |
|
The soluble CD83 protein prevents bone destruction by inhibiting the formation of osteoclasts and inducting resolution of inflammation
Dmytro Royzman, Darja Andreev, Lena Stich, Katrin Peckert-Maier, Andreas Wild, Elisabeth Zinser, Petra Mühl-Zürbes, Evan Jones, Susanne Adam, Silke Frey, Maximilian Fuchs, Meik Kunz, Tobias Bäuerle, Lisa Nagel, Georg Schett, Aline Bozec, Alexander Steinkasserer |
Frontiers in immunology | 2022 |
|
Marginal Zone B-Cell Populations and Their Regulatory Potential in the Context of HIV and Other Chronic Inflammatory Conditions
K Doyon-Laliberté, M Aranguren, J Poudrier, M Roger |
International journal of molecular sciences | 2022 |
|
Tilting the Balance: Therapeutic Prospects of CD83 as a Checkpoint Molecule Controlling Resolution of Inflammation
K Peckert-Maier, D Royzman, P Langguth, A Marosan, A Strack, A Shermeh, A Steinkasserer, E Zinser, A Wild |
International journal of molecular sciences | 2022 |
|
Bovine Peripheral Blood Derived Lymphocyte Proteome and Secretome Show Divergent Reaction of Bovine Immune Phenotypes after Stimulation with Pokeweed Mitogen
K Kleinwort, R Degroote, S Hirmer, L Korbonits, L Lorenz, A Scholz, S Hauck, C Deeg |
Proteomes | 2022 |
|
DNA Methylation of T Lymphocytes as a Therapeutic Target: Implications for Rheumatoid Arthritis Etiology
J Zhao, K Wei, C Chang, L Xu, P Jiang, S Guo, S Schrodi, D He |
Frontiers in immunology | 2022 |
|
Mucosal viral infection induces a regulatory T cell activation phenotype distinct from tissue residency in mouse and human tissues.
Traxinger B, Vick SC, Woodward-Davis A, Voillet V, Erickson JR, Czartoski J, Teague C, Prlic M, Lund JM |
Mucosal Immunology | 2022 |
|
Soluble CD83 improves and accelerates wound healing by the induction of pro-resolving macrophages
Royzman D, Peckert-Maier K, Stich L, König C, Wild AB, Tauchi M, Ostalecki C, Kiesewetter F, Seyferth S, Lee G, Eming SA, Fuchs M, Kunz M, Stürmer EK, Peters EM, Berking C, Zinser E, Steinkasserer A |
Frontiers in immunology | 2022 |
|
Common clonal origin of conventional T cells and induced regulatory T cells in breast cancer patients
M Xydia, R Rahbari, E Ruggiero, I Macaulay, M Tarabichi, R Lohmayer, S Wilkening, T Michels, D Brown, S Vanuytven, S Mastitskaya, S Laidlaw, N Grabe, M Pritsch, R Fronza, K Hexel, S Schmitt, M Müller-Steinhardt, N Halama, C Domschke, M Schmidt, C von Kalle, F Schütz, T Voet, P Beckhove |
Nature Communications | 2021 |
|
Granulocyte-macrophage colony-stimulating factor mRNA and Neuroprotective Immunity in Parkinson's disease
KE Olson, KL Namminga, Y Lu, MJ Thurston, AD Schwab, S de Picciotto, SW Tse, W Walker, J Iacovelli, C Small, BT Wipke, RL Mosley, E Huang, HE Gendelman |
Biomaterials | 2021 |
|
Epithelial cell‐derived CD83 restores immune tolerance in the airway mucosa by inducing regulatory T‐cell differentiation
LH Mo, XQ Luo, G Yang, JQ Liu, LT Yang, ZQ Liu, S Wang, DB Liu, ZG Liu, PC Yang |
Immunology | 2021 |
|
Human CD83-targeted chimeric antigen receptor T cells prevent and treat graft-versus-host disease
Bishwas Shrestha, Kelly Walton, Jordan Reff, Elizabeth M. Sagatys, Nhan Tu, Justin C. Boucher, Gongbo Li, Tayyeb Ghafoor, Martin Felices, Jeffrey Miller, Joseph Pidala, Bruce R. Blazar, Claudio Anasetti, Brian C. Betts, Marco L. Davila |
Journal of Clinical Investigation | 2020 |
|
Mutations in the notch signalling pathway are associated with enhanced anti‐tumour immunity in colorectal cancer
F Wang, J Long, L Li, Z Zhao, F Wei, Y Yao, WJ Qiu, ZX Wu, QQ Luo, W Liu, YB Quan, ZX Lian, J Cao |
Journal of Cellular and Molecular Medicine | 2020 |
|
Regulatory T cell control of systemic immunity and immunotherapy response in liver metastasis
JC Lee, S Mehdizadeh, J Smith, A Young, IA Mufazalov, CT Mowery, A Daud, JA Bluestone |
Science Immunology | 2020 |
|
Pre-Treatment Mutational and Transcriptomic Landscape of Responding Metastatic Melanoma Patients to Anti-PD1 Immunotherapy
CM Amato, JD Hintzsche, K Wells, A Applegate, NT Gorden, VM Vorwald, RP Tobin, K Nassar, YG Shellman, J Kim, TM Medina, M Rioth, KD Lewis, MD McCarter, R Gonzalez, AC Tan, WA Robinson |
Cancers | 2020 |
|
The CD83 Molecule – An Important Immune Checkpoint
L Grosche, I Knippertz, C König, D Royzman, AB Wild, E Zinser, H Sticht, YA Muller, A Steinkasserer, M Lechmann |
Frontiers in immunology | 2020 |
|
CD83 expression regulates antibody production in response to influenza A virus infection
M Akauliya, A Gautam, S Maharjan, BK Park, J Kim, HJ Kwon |
Virology Journal | 2020 |
|
CD83 orchestrates immunity towards self and non-self in dendritic cells
Andreas B. Wild, Lena Krzyzak, Katrin Peckert, Lena Stich, Christine Kuhnt, Alina Butterhof, Christine Seitz, Jochen Mattner, Niklas Grüner, Maximilian Gänsbauer, Martin Purtak, Didier Soulat, Thomas Winkler, Lars Nitschke, Elisabeth Zinser, Alexander Steinkasserer |
JCI Insight | 2019 |
|
Soluble CD83 Triggers Resolution of Arthritis and Sustained Inflammation Control in IDO Dependent Manner
D Royzman, D Andreev, L Stich, M Rauh, T Bäuerle, S Ellmann, L Boon, M Kindermann, K Peckert, A Bozec, G Schett, A Steinkasserer, E Zinser |
Frontiers in immunology | 2019 |
|
Putative loss of CD83 immunosuppressive activity in long-standing complication-free juvenile diabetic patients during disease progression
U Juhas, M Ryba-Stanisławowska, U Ławrynowicz, M Myśliwiec, J Myśliwska |
Immunologic Research | 2019 |
|
Endogenous Expression of the Human CD83 Attenuates EAE Symptoms in Humanized Transgenic Mice and Increases the Activity of Regulatory T Cells
E Zinser, R Naumann, AB Wild, J Michalski, A Deinzer, L Stich, C Kuhnt, A Steinkasserer, I Knippertz |
Frontiers in immunology | 2019 |
|
CD83: Activation Marker for Antigen Presenting Cells and Its Therapeutic Potential
Z Li, X Ju, PA Silveira, E Abadir, WH Hsu, DN Hart, GJ Clark |
Frontiers in immunology | 2019 |
|
T Regulatory Cells From Non-obese Diabetic Mice Show Low Responsiveness to IL-2 Stimulation and Exhibit Differential Expression of Anergy-Related and Ubiquitination Factors
GJ Godoy, C Olivera, DA Paira, FC Salazar, Y Ana, CC Stempin, RD Motrich, VE Rivero |
Frontiers in immunology | 2019 |
